Navigation Links
Clinical Outsourcing Leaders Summit Set to Convene November 13
Date:10/2/2008

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) is pleased to announce it will convene the inaugural Clinical Outsourcing Leaders Summit with a select group of senior pharmaceutical, biotech and clinical research executives November 13, 2008 in Washington, DC.

This exclusive event will feature high-level, interactive discussions surrounding the impact of the presidential election on biomedical research and various aspects of drug development. Among the featured speakers are:

Dr. Mark B. McClellan, Senior Fellow and Director of The Engelberg Center for Healthcare Reform at the Brookings Institution and former commissioner of the Food and Drug Administration;

Bill Thomas, former U.S. Congressman and former Chairman of the House Committee on Ways and Means. Currently a Senior Advisor to Buchanan, Ingersoll & Rooney PC and a Visiting Fellow at the American Enterprise Institute;

Dr. Andrew Dahlem, Vice President and COO, Eli Lilly Laboratories;

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research at the Food and Drug Administration;

Ken Getz, founder and chairman of the nonprofit CISCRP and a Senior Research Fellow at the Tufts Center for Drug Development, Tufts University Medical School;

Chris Singer, Executive Vice President and COO of PhRMA;

David Spaight, Chair of the ACRO Board of Directors and President of MDS Pharma Services;

Dr. Dennis Gillings, founding Chair of ACRO and Chairman and CEO of Quintiles Transnational Corp.

"Regardless of the outcome of the November elections, we know the drug development industry will face significant changes in the coming years," said ACRO Executive Director, Doug Peddicord, Ph.D. "This summit will bring together thought leaders from the biopharmaceutical and clinical outsourcing industries for an open dialogue on the political, economic and regulatory aspects of the changing healt
'/>"/>

SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
2. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
3. What is the clinical features of primary aortoenteric fistula?
4. Medicare HMO costs may prevent cancer patient clinical trial participation
5. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
6. Novel tuberculosis vaccine in Germany in clinical phase
7. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
8. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
9. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
10. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
11. New probe to detect skin cancer receives more funding for clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The microscopy market is estimated ... reach $5,756.0 million by 2019. Optical microscopy is ... electron microscopes product segment is expected to show ... Rising focus on nanotechnology, technological advancements, and increasing ... market. , Get Full Copy of Report @ ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. TS-1 is an anti-cancer drug which is typically ... and is also used for treating gastric cancer and ... otastat potassium. The drug was first approved in 1999 ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... International Cancer Research team has come out with the startling ... development of tumors in mice. This discovery could be vital ... molecules work by blocking the hormones that are essential for ... they strangle the tumor by blocking blood and nutrient supply ...
... turning their backs on tanning amid growing concerns over skin ... survey shows that teenagers are resisting the urge to tan ... 5,073 Australian adults and 699 Australian teenagers aged 12 to ... that 68 % of those aged 12-17 said they had ...
... part of the school curriculum from Class IX in all ... the age of 25. The new curriculum would be made ... the Human Resource Department of Government of India and National ... ministry has also made it compulsory to train teachers on ...
... have reacted with skepticism to a British man's claims that he ... some relief. // , ,In what is assumed as a ... now available in India. , ,This medicine is provided in ... that it would help the infected people to lead a much ...
... are unconcerned with the effect of their habit on the ... the damage // that smoking caused to the tongue or ... strangely reluctant to change their habits. This is of particular ... a massive awareness campaign as a part of the Mouth ...
... a doctor's permission is good at any time of life, ... study. // ,Thomas Foster and other scientists from the McKnight ... of rats that had lived to old age. Some were ... , ,Scientists examined chemical compounds in 41 tissue samples ...
Cached Medicine News:Health News:Aussie teens applauded for declining sun tan 2Health News:Regular light exercise slows down aging of the brain 2
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
(Date:12/22/2014)... Pa. and STOCKHOLM , ... (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced ... (CHMP) of the European Medicines Agency (EMA) has adopted ... clostridium histolyticum) for the treatment of adult men with ... of at least 30 degrees at the start of ...
(Date:12/22/2014)... 22, 2014  Eiger BioPharmaceuticals Incorporated announced the ... lonafarnib in patients with chronic hepatitis delta virus ... National Institutes of Health (NIH) Clinical Center in ... randomized, placebo-controlled, dose ascending study evaluated two doses ... mg twice daily for 28 days.  "This proof-of-concept ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... (Pink Sheets: MDBX ) ( www.thedispensingsolution.com ), ... to MDBX.  The company previously announced that their name ... The company is a leader in the design, manufacture ... The free-standing unit features 60 or more slots that ...
... 2011 This year, the melanoma community saw the first ... This major step forward will give more than 400 party-goers ... Gala.  They will gather at the Trump National Golf Club ... these cutting-edge advances and raise money for future research through ...
Cached Medicine Technology:MedBox Announces Ticker Symbol Change 2Washington, D.C. Melanoma Patient Community Celebrates Treatment Advances 2Washington, D.C. Melanoma Patient Community Celebrates Treatment Advances 3
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Barr periosteal elevators....
Seldin periosteal elevators....
Williger periosteal elevators....
Medicine Products: